Steris PLC STE

Morningstar Rating
$217.84 −3.29 (1.49%)
View Full Chart

Company Report

Narrow-Moat Steris' Recurring Revenue and Leverage Improvements Create Opportunistic Outlook

Steris is a leading provider of sterilization products and services to healthcare organizations, biopharma producers, and device manufacturers. The company also has a strong presence across operating rooms and endoscopy centers. Over the past few years, Steris has closed several acquisitions to enhance its healthcare offerings. With more procedures shifting to an outpatient setting, we think Steris’ expanded product portfolio positions itself as a “one-stop shop” that supplies mission-critical sterilization equipment and services. The burgeoning ambulatory surgery centers and physicians’ offices should benefit the most when sourcing from Steris, as they don’t necessarily have the capacity to deal with multiple vendors.

Price vs Fair Value

STE is trading at a LOCK|<^!ZRX premium.
Price
$217.84
Fair Value
LOCK|>Z
Uncertainty
LOCK|#vC!&
1-Star Price
LOCK|b.<Z
5-Star Price
LOCK|<.!F
Economic Moat
LOCK|%N%g
Capital Allocation
LOCK|G$LyMN!

Bulls Say, Bears Say

Bulls

Steris’ technological leadership in applied sterilization technologies, or AST, could attract new customers that lack the capacity to navigate regulatory challenges.

Bears

Steris’ frequent acquisitions may not always achieve promised synergies, especially for businesses operating in niche verticals like dental or renal.

Trading Information

Previous Close Price
$221.13
Day Range
$216.97222.54
52-Week Range
$195.14269.44
Bid/Ask
$214.92 / $229.47
Shares Outstanding
97.46M
Market Cap
$21.23B
Volume/Avg
622,613 / 815,516

Key Statistics

Price/Earnings (Normalized)
21.42
Price/Sales
3.62
Dividend Yield (Trailing)
1.16%
Dividend Yield (Forward)
1.16%
Total Yield
2.27%

Company Profile

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Core
Total Number of Employees
17,937

Competitors

Valuation

Metric
STE
GETI B
MDT
Price/Earnings (Normalized)
21.4220.8015.21
Price/Book Value
2.972.052.15
Price/Sales
3.621.852.95
Price/Cash Flow
16.3611.9912.24
Price/Earnings
STE
GETI B
MDT

Financial Strength

Metric
STE
GETI B
MDT
Quick Ratio
1.340.741.36
Current Ratio
2.091.312.13
Interest Coverage
18.097.269.58
Quick Ratio
STE
GETI B
MDT

Profitability

Metric
STE
GETI B
MDT
Return on Assets (Normalized)
9.62%5.12%7.76%
Return on Equity (Normalized)
14.41%9.77%14.65%
Return on Invested Capital (Normalized)
11.49%8.14%9.93%
Return on Assets
STE
GETI B
MDT

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|!M^MvLLOCK|<l^v$175B
Stryker Corp
SYK
LOCK|y#Vy#b$LOCK|Tj$123B
Medtronic PLC
MDT
LOCK|>x@$FGLOCK|X^^&C$106B
Boston Scientific Corp
BSX
LOCK|XM$^^!LOCK|F>B$v$65B
Edwards Lifesciences Corp
EW
LOCK|%n?%%#dLOCK|wc<#d$49B
DexCom Inc
DXCM
LOCK|GLSjhw?<LOCK|k#n^#$30B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|prf#J^@LOCK|Yr%$29B
Koninklijke Philips NV ADR
PHG
LOCK|FjfLOCK|N$$26B
Zimmer Biomet Holdings Inc
ZBH
LOCK|QlDNsV?NLOCK|p$$$18B

Sponsor Center